Real-world multicenter analysis of CPX-351 efficacy in patients aged less than 60 years with secondary acute myeloid leukemia

Blood Cancer J. 2025 Oct 26;15(1):181. doi: 10.1038/s41408-025-01394-7.
No abstract available

Publication types

  • Letter